Enterococci as Increasing Bacteria in Hospitals: Why Are Infection Control Measures Challenging for This Bacteria?

Enterococci as Increasing Bacteria in Hospitals: Why Are Infection Control Measures Challenging... Purpose of the review Enterococci are emerging threatening multidrug-resistant bacteria. Enterococcus faecium is a common pathogen associated with severe hospital-acquired infections. The goal of this report is to analyze the evolution of this nosocomial pathogen and study the state of adequate infection control measures. Recent findings Evolution over millions of years has allowed enterococci to develop into a persistent hospital pathogen, an environment where it thrives. Vancomycin-resistant enterococci (VRE) continues to obtain antibiotic resistance elements. Enterococci assem- ble multiple virulence factors. VRE intestinal colonization can promote nosocomial infec- tions. New rapid PCR laboratory tests with high sensitivity and specificity allows for screening of Enterococci in asyptomatic carriers. Summary The efficient clonal dissemination of VRE has led to a potential multidrug- resistant bacteria that is a current and future threat to hospitals worldwide. The thera- peutic options are few and decreasing. Healthcare-associated infection (HAI) prevention is critical in our fight against enterococci. 130 Treatment and Prevention of Hospital Infections (D Vilar-Compte, Section Editor) Introduction Enterococci, specifically vancomycin-resistant entero- baumanni, Pseudomonas aeruginosa,and Enterobacter spp., cocci (VRE), are important nosocomial pathogens all of which are dangerous threats [9]. worldwide [1, 2, 3�� , 4, 5� ]. Healthcare-associated in- Enterococcus also possess multiple http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Treatment Options in Infectious Diseases Springer Journals

Enterococci as Increasing Bacteria in Hospitals: Why Are Infection Control Measures Challenging for This Bacteria?

Loading next page...
 
/lp/springer_journal/enterococci-as-increasing-bacteria-in-hospitals-why-are-infection-TR0fpPBmP6
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Infectious Diseases
eISSN
1534-6250
D.O.I.
10.1007/s40506-018-0166-8
Publisher site
See Article on Publisher Site

Abstract

Purpose of the review Enterococci are emerging threatening multidrug-resistant bacteria. Enterococcus faecium is a common pathogen associated with severe hospital-acquired infections. The goal of this report is to analyze the evolution of this nosocomial pathogen and study the state of adequate infection control measures. Recent findings Evolution over millions of years has allowed enterococci to develop into a persistent hospital pathogen, an environment where it thrives. Vancomycin-resistant enterococci (VRE) continues to obtain antibiotic resistance elements. Enterococci assem- ble multiple virulence factors. VRE intestinal colonization can promote nosocomial infec- tions. New rapid PCR laboratory tests with high sensitivity and specificity allows for screening of Enterococci in asyptomatic carriers. Summary The efficient clonal dissemination of VRE has led to a potential multidrug- resistant bacteria that is a current and future threat to hospitals worldwide. The thera- peutic options are few and decreasing. Healthcare-associated infection (HAI) prevention is critical in our fight against enterococci. 130 Treatment and Prevention of Hospital Infections (D Vilar-Compte, Section Editor) Introduction Enterococci, specifically vancomycin-resistant entero- baumanni, Pseudomonas aeruginosa,and Enterobacter spp., cocci (VRE), are important nosocomial pathogens all of which are dangerous threats [9]. worldwide [1, 2, 3�� , 4, 5� ]. Healthcare-associated in- Enterococcus also possess multiple

Journal

Current Treatment Options in Infectious DiseasesSpringer Journals

Published: Apr 20, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off